231 related articles for article (PubMed ID: 11582643)
1. [One year of neonatal screening for sickle-cell disease in Emma Children's Hospital/Academic Medical Center in Amsterdam].
Heijboer H; van den Tweel XW; Peters M; Knuist M; Prins J; Heymans HS
Ned Tijdschr Geneeskd; 2001 Sep; 145(37):1795-9. PubMed ID: 11582643
[TBL] [Abstract][Full Text] [Related]
2. [Recognition of children with sickle cell disease in The Netherlands].
Heijboer H; Van den Tweel XW; Fijnvandraat K; Peters M
Ned Tijdschr Geneeskd; 2007 Nov; 151(45):2498-501. PubMed ID: 18062592
[TBL] [Abstract][Full Text] [Related]
3. [Genetic carrier screening for hemoglobinopathies in the Netherlands is not opportune].
Schulpen TW; van der Lee JH; van der Most van Spijk MW; Beemer FA
Ned Tijdschr Geneeskd; 1998 May; 142(18):1019-22. PubMed ID: 9623203
[TBL] [Abstract][Full Text] [Related]
4. [Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area].
Diallo DA; Guindo A; Touré BA; Sarro YS; Sima M; Tessougué O; Baraika MA; Guindo P; Traoré M; Diallo M; Dorie A
Rev Epidemiol Sante Publique; 2018 May; 66(3):181-185. PubMed ID: 29625861
[TBL] [Abstract][Full Text] [Related]
5. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
[TBL] [Abstract][Full Text] [Related]
6. [Neonatal screening for sickle cell disease at the Nice University Hospital: the last 8 years].
Berthet S; Monpoux F; Soummer AM; Bérard E; Sarles J; Badens C
Arch Pediatr; 2010 Dec; 17(12):1652-6. PubMed ID: 21087846
[TBL] [Abstract][Full Text] [Related]
7. Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates.
Al Hosani H; Salah M; Osman HM; Farag HM; Anvery SM
East Mediterr Health J; 2005 May; 11(3):300-7. PubMed ID: 16602448
[TBL] [Abstract][Full Text] [Related]
8. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
Nnodu OE; Sopekan A; Nnebe-Agumadu U; Ohiaeri C; Adeniran A; Shedul G; Isa HA; Owolabi O; Chianumba RI; Tanko Y; Iyobosa JH; Adekile AD; Olopade OI; Piel FB
Lancet Haematol; 2020 Jul; 7(7):e534-e540. PubMed ID: 32589979
[TBL] [Abstract][Full Text] [Related]
9. Neonatal screening for sickle cell disorders in Ouagadougou, Burkina Faso: a pilot study.
Kafando E; Sawadogo M; Cotton F; Vertongen F; Gulbis B
J Med Screen; 2005; 12(3):112-4. PubMed ID: 16156939
[TBL] [Abstract][Full Text] [Related]
10. Universal neonatal screening for sickle cell disease and other haemoglobinopathies in Ferrara, Italy.
Ballardini E; Tarocco A; Marsella M; Bernardoni R; Carandina G; Melandri C; Guerra G; Patella A; Zucchelli M; Ferlini A; Bigoni S; Ravani A; Garani G; Borgna-Pignatti C
Blood Transfus; 2013 Apr; 11(2):245-9. PubMed ID: 23058858
[TBL] [Abstract][Full Text] [Related]
11. [Genetic carrier screening for hemoglobinopathies: the situation in the Netherlands compared with England].
van Rhee MA; Holm JP; Niermeijer MF
Ned Tijdschr Geneeskd; 1998 May; 142(18):996-7. PubMed ID: 9623197
[TBL] [Abstract][Full Text] [Related]
12. Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies.
Tshilolo L; Kafando E; Sawadogo M; Cotton F; Vertongen F; Ferster A; Gulbis B
Public Health; 2008 Sep; 122(9):933-41. PubMed ID: 18555498
[TBL] [Abstract][Full Text] [Related]
13. The pattern of sickle cell disease in pregnancy in Lagos, Nigeria.
Ogedengbe OK; Akinyanju O
West Afr J Med; 1993; 12(2):96-100. PubMed ID: 8398940
[TBL] [Abstract][Full Text] [Related]
14. Community based screening for sickle haemoglobin among pregnant women in Benue State, Nigeria: I-Care-to-Know, a Healthy Beginning Initiative.
Ezenwosu OU; Itanyi IU; Nnodu OE; Ogidi AG; Mgbeahurike F; Ezeanolue EE
BMC Pregnancy Childbirth; 2021 Jul; 21(1):498. PubMed ID: 34238241
[TBL] [Abstract][Full Text] [Related]
15. Newborn screening for sickle cell diseases in the United States: A review of data spanning 2 decades.
Therrell BL; Lloyd-Puryear MA; Eckman JR; Mann MY
Semin Perinatol; 2015 Apr; 39(3):238-51. PubMed ID: 25979783
[TBL] [Abstract][Full Text] [Related]
16. [Application of the polymerase chain reaction to the diagnosis of sickle cell anemia in Venezuela].
Martínez J; Blanco Z; Hakshaw P; Moreno N
Sangre (Barc); 1998 Feb; 43(1):63-6. PubMed ID: 9577183
[TBL] [Abstract][Full Text] [Related]
17. Neonatal/newborn haemoglobinopathy screening in Europe and Africa.
Bain BJ
J Clin Pathol; 2009 Jan; 62(1):53-6. PubMed ID: 19103862
[TBL] [Abstract][Full Text] [Related]
18. [Haemoglobinopathy in the 21st century: incidence, diagnosis and heel prick screening].
Suijker MH; Roovers EA; Fijnvandraat CJ; Dors N; Rodrigues Pereira R; Giordano PC; Verkerk PH; Peters M
Ned Tijdschr Geneeskd; 2014; 158():A7365. PubMed ID: 25052352
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of preoperative screening for sickle cell disease in a population with a newborn screening program: a cohort study.
O'Leary JD; Odame I; Pehora C; Chakraborty P; Crawford MW
Can J Anaesth; 2013 Jan; 60(1):54-9. PubMed ID: 23104576
[TBL] [Abstract][Full Text] [Related]
20. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
Steele C; Sinski A; Asibey J; Hardy-Dessources MD; Elana G; Brennan C; Odame I; Hoppe C; Geisberg M; Serrao E; Quinn CT
Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
